Home Cart 0 Sign in  

[ CAS No. 141-05-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 141-05-9
Chemical Structure| 141-05-9
Structure of 141-05-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 141-05-9 ]

Related Doc. of [ 141-05-9 ]

Alternatived Products of [ 141-05-9 ]

Product Details of [ 141-05-9 ]

CAS No. :141-05-9 MDL No. :MFCD00009191
Formula : C8H12O4 Boiling Point : -
Linear Structure Formula :- InChI Key :IEPRKVQEAMIZSS-WAYWQWQTSA-N
M.W : 172.18 Pubchem ID :5271566
Synonyms :
Maleic acid diethyl ester;Diethyl ester;AI3-00678;NSC 8394
Chemical Name :Diethyl (Z)-2-butenedioate

Calculated chemistry of [ 141-05-9 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.5
Num. rotatable bonds : 6
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.67
TPSA : 52.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.68 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.42
Log Po/w (XLOGP3) : 0.94
Log Po/w (WLOGP) : 0.67
Log Po/w (MLOGP) : 0.84
Log Po/w (SILICOS-IT) : 0.99
Consensus Log Po/w : 1.17

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.1
Solubility : 13.6 mg/ml ; 0.0788 mol/l
Class : Very soluble
Log S (Ali) : -1.63
Solubility : 4.02 mg/ml ; 0.0234 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.93
Solubility : 20.3 mg/ml ; 0.118 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.34

Safety of [ 141-05-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P260-P264-P270-P271-P272-P273-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P312-P333+P313-P337+P313-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302-H313-H317-H319-H335-H373-H401 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 141-05-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 141-05-9 ]
  • Downstream synthetic route of [ 141-05-9 ]

[ 141-05-9 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 15930-53-7 ]
  • [ 141-05-9 ]
  • [ 6642-34-8 ]
Reference: [1] Tetrahedron, 1996, vol. 52, # 4, p. 1389 - 1398
  • 2
  • [ 107-15-3 ]
  • [ 141-05-9 ]
  • [ 33422-35-4 ]
YieldReaction ConditionsOperation in experiment
100% at 55℃; for 16 h; Synthesis of 2-(1-(2,4-dichlorophenylsulfonyl)-3-oxopiperazin-2-yl)acetic acid S11; Ethyl 2-(3-oxopiperazin-2-yl)acetate; Ethylenediamine (1.17 ml, 17.42 mmol) and diethyl maleate (3 g, 17.42 mmol) were stirred for 16 h at 55° C. in propanol (30 ml). The solvent was removed in vacuo and the residue was dried in vacuo. The product was used in the next stage without being purified further.Yield: 3.4 g (100percent)
Reference: [1] Patent: US2008/312231, 2008, A1, . Location in patent: Page/Page column 40
[2] Journal of Heterocyclic Chemistry, 1993, vol. 30, # 1, p. 275 - 276
[3] Journal of Pharmaceutical Sciences, 1990, vol. 79, # 5, p. 447 - 452
  • 3
  • [ 109-99-9 ]
  • [ 623-73-4 ]
  • [ 2434-02-8 ]
  • [ 623-91-6 ]
  • [ 141-05-9 ]
Reference: [1] Tetrahedron Letters, 1989, vol. 30, # 14, p. 1749 - 1752
  • 4
  • [ 27332-37-2 ]
  • [ 34046-43-0 ]
  • [ 93-89-0 ]
  • [ 6287-86-1 ]
  • [ 101-97-3 ]
  • [ 141-05-9 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1993, vol. 41, # 12, p. 2187 - 2189
  • 5
  • [ 141-05-9 ]
  • [ 2459-05-4 ]
Reference: [1] Journal of the Chemical Society, 1891, vol. 59, p. 739
  • 6
  • [ 75-07-0 ]
  • [ 141-05-9 ]
  • [ 1115-30-6 ]
Reference: [1] Journal of Organic Chemistry, 1952, vol. 17, p. 1009,1010, 1011[2] Org. Synth. Coll., 1963, vol. Vol. IV, p. 430
[3] Journal of Organic Chemistry, 1952, vol. 17, p. 1009,1010, 1011[4] Org. Synth. Coll., 1963, vol. Vol. IV, p. 430
  • 7
  • [ 75-07-0 ]
  • [ 141-05-9 ]
  • [ 94-36-0 ]
  • [ 1115-30-6 ]
Reference: [1] Journal of Organic Chemistry, 1952, vol. 17, p. 1009,1010, 1011[2] Org. Synth. Coll., 1963, vol. Vol. IV, p. 430
  • 8
  • [ 141-05-9 ]
  • [ 1187-74-2 ]
Reference: [1] Patent: CN105085263, 2017, B,
  • 9
  • [ 623-73-4 ]
  • [ 35059-50-8 ]
  • [ 18305-60-7 ]
  • [ 141-05-9 ]
Reference: [1] Chemistry - A European Journal, 2007, vol. 13, # 12, p. 3470 - 3479
  • 10
  • [ 1774-47-6 ]
  • [ 141-05-9 ]
  • [ 710-43-0 ]
  • [ 3999-55-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, # 12, p. 2921 - 2926
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, # 12, p. 2921 - 2926
  • 11
  • [ 1774-47-6 ]
  • [ 141-05-9 ]
  • [ 710-43-0 ]
  • [ 3999-55-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, # 12, p. 2921 - 2926
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, # 12, p. 2921 - 2926
Same Skeleton Products
Historical Records